Using a meta-analysis approach on three merged BrCa ER datasets, and focusing on the well-known ErbB signaling pathway, we provided indicative evidence for the power of MinePath to identify and reveal important molecular cancer-related regulatory operations that governs the expression of specific BrCa phenotypes. Here, EGFR is linked to cancer.